UCLA and Caltech Study Uses Technology Being Commercialized by IsoPlexis To Characterize Cancer Cells Resistant to Targeted Treatments
BioTech Gate,
BRANFORD, Conn., Dec. 14, 2017 /PRNewswire-USNewswire/ -- Researchers from Caltech and UCLA used novel single-cell…